TNIE GER Week ended 07 Aug 2026

Weekly Investor Report

tonies SE · Consumer Cyclical · Leisure

Open interactive chart View report data
Latest close 12.04 EUR
-2.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 8.1% above the Trend Line and sits at 82.1% of its 52-week range. The latest completed week returned -2.0%, after a -4.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 64/100.

Setup score 66 out of 100
Latest Close 12.04 EUR 7 Aug 2026
1W Return -2.0% latest completed week
4W Return -4.1% short-term follow-through
12W Return 14.4% quarterly tape
Trend Breadth 96.2% 50 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 50-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.0% Latest completed week; four-week move -4.1%. Indicator stack 98/59 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.83% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 64/100 12 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 8.1% above the Trend Line and sits at 82.1% of its 52-week range. The latest completed week returned -2.0%, after a -4.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9112-week average 0.66

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.91Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.1% over four weeks, 14.4% over 12 weeks, and 103.0% over one year. The current trend has remained active for 50 consecutive weeks.

Performance by holding period

1W-2.0%
4W-4.1%
12W14.4%
26W7.9%
52W103.0%
Active trend streak50 weeks
Active weeks in one year50
Trend breadth96.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.63Latest activity-pressure read.
Pressure change-35.5%Four-week change in activity pressure.
Leadership11.80Latest relative-leadership reading.
RS change-58.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 88% Model confidence 70%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength13/100Blend of value, momentum, and quality. Underlying universe rank 88; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality24/100Profitability and accounting quality. Underlying universe rank 77; rank 1 is best.
Momentum94/100Medium-term price momentum. Underlying universe rank 7; rank 1 is best.
Growth78/100Revenue and earnings growth. Underlying universe rank 23; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
111.9x
Price divided by trailing earnings.
Price / sales
2.3x
Market value relative to trailing revenue.
EV / EBITDA
35.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
51.8%
Gross profit retained from each unit of revenue.
Operating margin
4.4%
Operating profit retained from revenue.
Free-cash-flow margin
-2.1%
Free cash flow generated from revenue.
Return on invested capital
6.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
31.2%
Latest one-year revenue growth.
EPS growth
-0.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-142.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment64/100

Weighted news tone is positive across 12 relevant articles.

7 positive · 5 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.3%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+11.6%Week of 19 Jun.
Worst week-6.1%Week of 6 Mar.
Latest week-2.0%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains8
Flat weeks0
Modest losses8
Sharp losses5
Recent vol5.3%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryDE Leisure
4-week rank2 / 2
Group average-0.3%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD100.0%positive activity pressure
RS50.0%positive relative leadership

Four-week leaders

ULC · GER3.6%TNIE · GER-4.1%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape70/100

Trend, activity pressure, participation, and risk combine to a 70/100 tape read.

 Indicator analysis79/100

Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 12/12.

Activity pressure 0.91; 2 reversal markers Next-Week ExpectancyPositive 55.83%

Next-week expectancy is positive with a 55.83% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors31/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 91; Small Cap Core rank 99 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment64/100

Weighted news tone is positive across 12 relevant articles.

Original-Research: tonies SE (von NuWays AG): BUY Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202612.04 EUR-2.0%11.14 EUR7.24 EUR0.6311.80675.0KOn
31 Jul 202612.28 EUR-5.2%11.10 EUR7.19 EUR0.7818.28866.0KOn
24 Jul 202612.96 EUR9.5%11.04 EUR7.15 EUR0.8128.88672.8KOn
17 Jul 202611.84 EUR-5.7%10.94 EUR7.09 EUR0.7620.57336.6KOn
10 Jul 202612.56 EUR-1.9%10.87 EUR7.05 EUR0.9828.19841.1KOn
3 Jul 202612.80 EUR3.7%10.76 EUR7.00 EUR0.8528.73216.9KOn
26 Jun 202612.34 EUR-4.3%10.64 EUR6.95 EUR0.4431.33144.3KOn
19 Jun 202612.90 EUR11.6%10.56 EUR6.90 EUR0.0537.28793.2KOn
12 Jun 202611.56 EUR6.4%10.43 EUR6.85 EUR-0.4626.56218.9KOn
5 Jun 202610.86 EUR0.4%10.33 EUR6.81 EUR-0.7819.62178.2KOn
29 May 202610.82 EUR2.7%10.24 EUR6.77 EUR-0.8418.66524.1KOn
22 May 202610.54 EUR0.2%10.17 EUR6.73 EUR-0.9517.73510.9KOn
15 May 202610.52 EUR4.2%10.11 EUR6.70 EUR-0.9723.17877.6KOn
8 May 202610.10 EUR-1.8%10.04 EUR6.66 EUR-0.9617.43529.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context